The successful integration of research and care: How pediatric oncology became the subspecialty in which research defines the standard of care

Pediatric Blood and Cancer

Volumn 56, Issue 7, 2011, Pages 1019-1025

  Unguru, Yoram ^a,b  

^a The Herman & Walter Samuelson Children's Hospital at Sinai   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Childhood cancer; Clinical trials; Cooperative groups; Ethics; History

Indexed keywords

MERCAPTOPURINE; METHOTREXATE;

CANCER RESEARCH; CHILD CARE; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; MULTICENTER STUDY (TOPIC); PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

BIOMEDICAL RESEARCH; CHILD; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE; PEDIATRICS; STANDARD OF CARE;

EID: 79954517832     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22976     Document Type: Review

References (60)

1. Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-Aminopteroyl-Glutamic acid (Aminopterin). N Engl J Med 1948;238:787-793.
2. Laszlo J. The cure of childhood leukemia: Into the age of miracles. New Brunswick, New Jersey: Rutgers University Press; 1996.
3. Endicott K. The chemotherapy program. J Natl Cancer Inst 1957;19:275-293.
4. Interviews with C. Gordon Zubrod, NCI Oral History Project, History Associates Incorporated, 27 May and 27 June 1997, p. 69 as cited in Keating P and Cambrosio A. From screening to clinical research: The cure of leukemia and the early development of the cooperative oncology groups, 1956-1966. Bull Hist Med 2002;76:299-334.
5. Frei E III, Freireich EJ, Gehan E, et al. Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-Mercaptopurine and methotrexate. Blood 1961;18:431-454.
6. Freireich EJ, Karon M, Frei E III. Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood. Proc Am Assoc Cancer Res 1964;5:20 (abstract).
7. Zubrod CG. Historic milestones in curative chemotherapy. Semin Oncol 1979;6:490-505.
8. Krueger G. Hope and suffering: Children, cancer, and the paradox of experimental medicine. Baltimore: The Johns Hopkins University Press; 2008.
9. Bleyer WA. The U.S. pediatric cancer clinical trials programmes: International implications and the way forward. Eur J Cancer 1997;33:1439-1447.
10. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979). The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office.
11. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent Rep 1987;17:20-24.
12. Levine R. Ethics and regulation of clinical research, 2nd edition. New Haven, CT: Yale University Press; 1988.
13. Miller FG, Brody H. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep 2003;33:19-28.
14. Joffe S, Miller FG. Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol 2006;24:2987-2990.
15. Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812-816.
16. National Cancer Institute. Cancer clinical trials: The basic workbook. Available at: Accessed February 13, 2010.
17. Meinkoff J, Richards EP. What the doctor didn't say: The hidden truth about medical research. New York: Oxford University Press; 2006.
18. Joffe S, Weeks JC. Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst 2002;94:1847-1853.
19. de Vries MC, Wit JM, Engberts DP, et al. Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation. Pediatr Blood Cancer 2010;55:123-128.
20. Kodish ED, Pentz RD, Noll RB, et al. Informed consent in the Children's Cancer Group. Cancer 1998;82:2467-2481.
21. Brody H, Miller FG. The clinician-investigator: Unavoidable but manageable tension. Kennedy Inst Ethics J 2003;13:329-346.
22. Keating P, Cambrosio A. From screening to clinical research: The cure of leukemia and the early development of the cooperative oncology groups, 1956-1966. Bull Hist Med 2002;76:299-334.
23. Zubrod CG. The fifth Myron Karon Memorial Lecture. The cure of cancer by chemotherapy-Reflections on how it happened. Med Pediatr Oncol 1980;8:107-114.
24. Freireich EJ, Frei E III, Holland JF, et al. Evaluation of a new chemotherapeutic agent in patients with "advanced refractory" acute leukemia: Studies of 6-Azauracil. Blood 1960;16:1268-1278.
25. Marshall G, Blacklock JWS, Cameron C, et al. Streptomycin treatment of pulmonary tuberculosis: A Medical Research Council investigation. Br Med J 1948;2:769-782.
26. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-2117.
27. Lantos J. The "inclusion benefit" in clinical trials. J Pediatr 1999;134:130-131.
28. Caldwell PH, Murphy SB, Butow PN, et al. Clinical trials in children. Lancet 2004;364:803-811.
29. Smyth RL, Weindling AM. Research in children: Ethical and scientific aspects. Lancet 1999;354:21-24.
30. Joffe S. Framing the benefits of cancer clinical trials. Arch Pediatr Adolesc Med 2010;164:293-294.
31. Vist GE, Bryant D, Somerville L, et al. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev 2008;3:MR000009.
32. Stiller CA, Benjamin S, Cartwright R, et al. Patterns of care and survival for adolescents and young adults with acute lymphoblastic leukemia-A population-based study. Br J Cancer 1999;79:658-665.
33. Koschmann C, Thomson B, Hawkins DS. No evidence of a trial effect in newly diagnosed pediatric acute lymphoblastic leukemia. Arch Pediatr Adolesc Med 2010;164:214-217.
34. Stiller CA, Eatock E. Patterns of care and survival for children with acute lymphoblastic leukemia diagnosed between 1980 and 1994. Arch Dis Child 1999;81:202-208.
35. Peppercorn JM, Weeks J, Cook E, et al. Comparison of outcomes in cancer patients treated within and outside clinical trials: Conceptual framework and structured review. Lancet 2004;363:263-270.
36. Cancer Statistics 2009 Presentation. A Presentation From the American Cancer Society. Available at: Accessed February 27, 2010.
37. Childhood Cancers: Questions and Answers. National Cancer Institute FactSheet. Available at: Accessed February 27, 2010.
38. van Eys J, Vietti TJ. Pediatric cooperative trial groups in the Eighties-Challenges and opportunities. Cancer Bull 1982;34:117-120.
39. Applebaum PS, Roth LH, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent Rep 1987;17:20-24.
40. Green MR, George SL, Schlisky RL. Tomorrow's cancer treatments today: The first 50 years of the Cancer and Leukemia Group B. Semin Oncol 2008;35:470-483.
41. Heyn RM, Brubaker CA, Burchenal JH, et al. The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children: Results of a cooperative study. Blood 1960;15:350-359.
42. Moore TB, McCabe ERB. National collaborative study groups: Structure, benefits gained and potential for rare genetic diseases. Genet Med 2006;8:793-796.
43. O'Leary M, Krailo M, Anderson JR, et al. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol 2008;35:484-489.
44. About COG. Available at Accessed March 4, 2010.
45. Nachman JB, Mei KL, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: A report from the Children's Oncology Group. J Clin Oncol 2009;27:5189-5194.
46. Simone JV. Miracle therapy for leukemia. Oncol Times 2010;32:6-7.
47. Kodish E. Pediatric ethics and early-phase childhood cancer research: Conflicted goals and the prospect of benefit. Accounts Res 2003;10:17-25.
48. U.S. Department of Health and Human Services. 45 CFR 46. Subpart D-Additional Protections for Children Involved as Subjects in Research. Federal Registrar 1983 March 8;48:9819. Available at Accessed March 8, 2010.
49. Freireich EJ, Schmidt PJ, Schneiderman MA, et al. A comparative study of the effect of transfusion of fresh and preserved whole blood on bleeding in patients with acute leukemia. N Engl J Med 1959;260:6-11.
50. Ackerman TF. The ethics of phase I pediatric oncology trials. IRB 1995;17:1-5.
51. Abigail Alliance. Available at Accessed March 8, 2010.
52. Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law 10 (Washington DC: Superintendent of Documents, U.S. Government Printing Office, 1950). Military Tribunal 1, Case 1, United States v. Karl Brandt et al., October 1946-April 1949, Vol. II, pp. 181-182.
53. For examples of children as research subjects in Nazi medical experiments, see Sara Seiler Vigorito. A Profile of Nazi Medicine: The Nazi Doctor-His Methods and Goals. In: Arthur Caplan, editor. When medicine went mad: Bioethics and the Holocaust. Totowa, New Jersey: Humana Press, 1992, 12. Mozes-Kor E. The Mengele twins and human experimentation: A personal account. In: George Annas and Michael Grodin, editors. The Nazi doctors and the Nuremberg Code: Human rights in human experimentation. New York: Oxford University Press; 1992. p. 57.
54. Krugman S, Ward R, et al. Infectious hepatitis: Detection of virus during the incubation period and its clinically inapparent infection. N Engl J Med 1959;261:729-734.
55. Advisory Committee on Human Radiation Experiments, Final Report (Washington, DC: U.S. Government Printing Office, 1995), 321, 342-345, 347.
56. Beecher H. Ethics and clinical research. N Engl J Med 1966;274:1354-1360.
57. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Research Involving Children: Report and Recommendations. Washington, DC: DHEW Publication No. (OS); 77-0044, 1977.
58. Burchenal JH, Ellison RR, Murphy ML, et al. Clinical studies on 6-mercaptopurine. Ann NY Acad Sci 1954;60:359-368.
59. Wells W, Elion G, Laszlo J. Curing childhood leukemia. In Beyond discovery: The path from research to human benefit. National Academy of Sciences. October 1997.
60. Freireich EJ, Karon M, Frei E III. Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood. Proc Am Ass Cancer Res 1964;5:20.